Vaxcyte, Inc. (PCVX) - Quarterly Income Statement

Home
PCVX
Financials

116.54 (USD) • At close September 18, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1
Revenue Numbers are in millions	0	0	14.446	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	3.478	3.091	2.948	2.48	2.401	2.342	2.3	2.354	2.164	2.369	1.206	0.846	0.868	0.527	0	0	0	0	0	0	0	0
Gross Profit Numbers are in millions	-3.478	-3.091	11.498	-2.48	-2.401	-2.342	-2.3	-2.354	-2.164	-2.369	-1.206	-0.846	-0.868	-0.527	0	0	0	0	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0	0.796	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	131.507	94.587	104.15	97.421	72.691	58.08	51.626	47.679	38.469	31.678	23.074	20.428	17.651	17.258	14.661	16.41	18.178	24.315	13.382	9.63	9.968	12.628
General & Administrative Expenses Numbers are in millions	21.474	19.885	17.526	15.605	14.456	13.112	11.952	10.898	9.417	7.543	6.772	6.523	6.079	5.885	4.792	4.898	3.046	3.281	2.457	2.51	2.264	1.316
Selling & Marketing Expenses Numbers are in millions	-3.478	0	-2.948	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	17.996	19.885	14.578	15.605	14.456	13.112	11.952	10.898	9.417	7.543	6.772	6.523	6.079	5.885	4.792	4.898	3.046	3.281	2.457	2.51	2.264	1.316
Other Expenses Numbers are in millions	0	0	75.654	0	0	-0.654	-0.925	-0.157	-0.69	-0.16	-0.908	-0.299	-0.378	0	0	0	0	0	0.665	0.844	1.45	0.226
Operating Expenses Numbers are in millions	149.503	114.346	118.728	113.026	84.683	70.538	62.653	58.42	47.196	39.061	28.938	26.652	23.352	23.143	19.127	20.521	20.188	27.267	15.656	12.086	12.232	13.944
Operating Income Numbers are in millions	-152.981	-114.472	-121.676	-113.026	-87.147	-71.192	-86.573	-58.577	-47.886	-39.221	-29.846	-26.951	-23.73	-23.143	-19.453	-21.308	-21.224	-27.596	-15.839	-12.14	-12.232	-13.944
Operating Income Ratio Numbers are in millions	0	0	-8.423	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	24.278	-2.34	-59.125	20.362	-0.107	10.73	8.523	0.66	-0.646	0.235	0.276	-0.053	-0.413	1.862	-1.642	-0.53	-0.176	-0.003	0.947	0.658	1.397	0.05
Income Before Tax Numbers are in millions	-128.703	-95.02	-180.801	-92.664	-68.339	-60.462	-78.05	-57.917	-48.532	-38.986	-28.563	-26.615	-23.679	-21.22	-20.737	-21.018	-20.32	-27.142	-14.621	-11.317	-10.665	-13.671
Income Before Tax Ratio Numbers are in millions	0	0	-12.516	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0	-19.326	14.581	-2.48	2.279	-12.101	15.397	-0.66	0.646	-0.235	0	0.01	0.007	0	-0.332	-0.334	0	0.007	0.672	0.853	1.461	0.239
Net Income Numbers are in millions	-128.703	-95.02	-180.801	-92.664	-68.339	-48.361	-93.447	-57.257	-49.178	-38.751	-28.563	-26.615	-23.679	-21.22	-20.737	-21.018	-20.32	-27.142	-14.621	-11.317	-10.665	-13.671
Net Income Ratio Numbers are in millions	0	0	-12.516	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-1.1	-0.85	-1.9	-0.91	-0.7	-0.56	-1.23	-0.92	-0.81	-0.67	-0.55	-0.51	-0.46	-0.41	-0.41	-0.41	-1.72	-0.58	-0.57	-0.44	-0.42	-0.53
EPS Diluted Numbers are in millions	-1.1	-0.85	-1.9	-0.91	-0.7	-0.56	-1.23	-0.92	-0.81	-0.67	-0.55	-0.51	-0.46	-0.41	-0.41	-0.41	-1.72	-0.58	-0.57	-0.44	-0.42	-0.53
EBITDA Numbers are in millions	-149.503	-108.915	-118.728	-113.026	-65.831	-70.221	-53.72	-57.23	-44.624	-36.633	-27.633	-25.706	-22.391	-22.555	-19.095	-20.488	-19.789	-26.748	-14.564	-10.818	-10.299	-13.188
EBITDA Ratio Numbers are in millions	0	0	-8.219	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Vaxcyte, Inc.

NASDAQ:PCVX Add to watchlist

NASDAQ:PCVX